Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy

Data ReadoutpositiveART27.13Positive

AI Analysis

Summary

Artelo Biosciences announced positive nonclinical model results for ART27.13 in treating paclitaxel-induced peripheral neuropathy in cancer patients. The data expands the potential therapeutic applications for managing neuropathic pain, particularly in cancer patients experiencing weight loss.

Outcome Details

Positive results in nonclinical model of paclitaxel-induced peripheral neuropathy

Importance:4/10

Sentiment:

0.60

nonclinical dataperipheral neuropathyneuropathic paincancer patientsART27.13

Related Companies

$ARTL

Read the original article

Published by GlobeNewswire Clinical Studies on July 13, 2026 1:02 PM

Read Original